Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant
Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-017-0046-8
Full Text
Open PDFAbstract
Available in full text
Date
January 12, 2018
Authors
Publisher
Springer Science and Business Media LLC